Trending Stocks By Analyst's for this Week
Aardvark Therapeutics was rated Buy by HC Wainwright, with a target price of $40.00. AbbVie received a Buy rating from Morgan Stanley, with a price target of $250.00. Aemetis had its target raised by UBS Group, reaffirming a Buy rating and lifting the price from $2.20 to $3.00. AeroVironment was initiated with a Buy rating by The Goldman Sachs Group, targeting $301.00. Affirm had its target raised by Barclays and maintained an Overweight rating, with the price increased from $67.00 to $80.00. Agnico Eagle Mines received an Outperform initiation from Raymond James Financial, with a target price of $130.00. Agree Realty was reiterated as Market Perform by JMP Securities. Air Products and Chemicals was reiterated with a Buy rating by Citigroup, increasing the target from $310.00 to $320.00. Alnylam Pharmaceuticals had its target raised by Wells Fargo & Company, maintaining an Equal Weight rating, and the price increased from $287.00 to $333.00. American Healthcare REIT was initiated at Sector Outperform by Scotiabank, with a target of $42.00. Amgen received a Buy rating from TD Cowen, with a price target of $389.00. Amgen was rated Hold by Morgan Stanley, with a target of $330.00. Amplify Energy was initiated with a Buy rating by Alliance Global Partners, with a price target of $6.00. Anglogold Ashanti PLC received a Buy rating from Roth MKM, with a target price of $54.00. Antero Resources was rated Hold by Citi, with a target of $45.00. Aramark was maintained at Equal Weight by Morgan Stanley, with a price target increase from $42.00 to $44.00. Argenx Se also received a Buy rating from Wells Fargo, targeting $741.00. Argenx Se was rated Buy by Citi, with a target price of $803.00. ARM had its target raised by Guggenheim, keeping a Buy rating and lifting the price from $147.00 to $187.00. Aurinia Pharmaceuticals was rated Buy by both Leerink Partners and TD Cowen, with targets of $10.00 and $11.00, respectively. Aytu BioPharma was given a Buy initiation by Ascendiant Capital Markets, with a target price of $12.00. B2Gold was initiated with an Outperform rating by Raymond James Financial, targeting $4.50. Baker Hughes Company was rated Buy by Wells Fargo, aiming for $50.00. Beazer Homes USA was initiated as Neutral by B. Riley, with a target of $23.00. BioCryst Pharmaceuticals had its Outperform rating reiterated by Royal Bank of Canada, with a target of $13.00. BioCryst received a Buy rating from BofA Securities, with a target of $15.00. Boeing was rated Buy by Citi, with a price target of $220.00. Boyd Gaming had its Outperform rating reaffirmed by Raymond James Financial, and its target raised from $81.00 to $85.00. BridgeBio Pharma had its target raised by Wells Fargo & Company, keeping an Overweight rating and raising the price from $67.00 to $76.00. BridgeBio Pharma received a Buy rating from Raymond James, with a price target of $57.00. Brookfield Asset Management was initiated with a Neutral rating by Piper Sandler, targeting $60.00. CAE was initiated with a Buy rating by The Goldman Sachs Group, with a target of $33.00. Candel Therapeutics received a Buy initiation from HC Wainwright, targeting $23.00. Capricor Therapeutics was initiated at Buy by Alliance Global Partners, with a price target of $20.00. CarMax received a Buy rating from Morgan Stanley, with a price target of $80.00. Celcuity had its Buy rating reiterated by Needham & Company LLC, with a target of $29.00. Celcuity received a Buy rating from LifeSci Capital, with a target of $27.00. Cencora was rated Hold by Jefferies Financial Group, with a raised target of $300.00. Century Communities was initiated with a Buy rating by B. Riley, targeting $70.00. Chemed had its Buy rating maintained by Bank of America, though the price target was lowered from $708.00 to $650.00. Cidara Therapeutics had its Market Outperform rating reiterated by JMP Securities, with a target of $59.00. Circle Internet Group was rated Buy by Canaccord Genuity Group, with a target price of $247.00. Circle Internet Group was rated Buy by Citigroup, with a target price of $243.00. Circle Internet Group was rated Buy by Needham & Company LLC, with a target price of $250.00. Circle Internet Group was rated Hold by Deutsche Bank Aktiengesellschaft, with a target price of $155.00. Circle Internet Group was rated Market Perform by Oppenheimer (no price target provided). Circle Internet Group was rated Neutral by The Goldman Sachs Group, with a target price of $83.00. Circle Internet Group was rated Outperform by Sanford C. Bernstein, with a target price of $230.00. Circle Internet Group was rated Overweight by Barclays, with a target price of $215.00. Circle Internet Group was rated Underweight by JPMorgan Chase & Co., with a target price of $80.00. Citius Pharmaceuticals was rated Buy by D. Boral Capital, with a target of $6.00. Clene was rated Buy by D. Boral Capital, with a target price of $23.00. Cloudastructure received a Buy rating from Maxim Group, targeting $6.00. Coeur Mining was rated Buy by Roth MKM, with a target price of $12.00. Cogent Biosciences was rated Neutral by Wedbush, targeting $10.00. Cohen & Steers was initiated with an Underperform rating by Bank of America, targeting $67.00. Comfort Systems USA was rated Buy by DA Davidson, and the price target was raised to $630.00. Concentrix was rated Buy by Canaccord Genuity Group, with a price target of $80.00. Consolidated Edison was upgraded to Outperform by Mizuho, with a target of $107.00. CoreCivic received a Buy rating from Texas Capital Securities, targeting $28.00. CorMedix was downgraded to Hold by D. Boral Capital (no new price target provided). Crocs was rated Buy by Bank of America, with a reduced target of $135.00. CVS Health was rated Buy by Jefferies Financial Group, with a new target of $80.00. Dave was rated Buy by Benchmark, with a raised price target of $320.00. Dayforce was rated Buy by Needham & Company LLC, targeting $95.00. Delek US was rated Outperform by Raymond James Financial, with a price target of $23.00. Dianthus Therapeutics was assigned a Buy rating by LifeSci Capital, with a target of $45.00. DoorDash was rated Outperform by Oppenheimer, targeting $280.00. Driven Brands was initiated as Buy by BTIG Research, targeting $22.00. Duolingo was rated Buy by Evercore ISI, targeting $540.00. Dutch Bros was initiated as Outperform by CICC Research, targeting $80.00. eBay was rated Equal Weight by Wells Fargo & Company, with a new target of $66.00. Edgewise Therapeutics was initiated with a Buy rating by HC Wainwright, with a price target of $42.00. Emerson Electric Company received a Buy rating from KeyBanc, with a price target of $155.00. Etsy was rated Underweight by Wells Fargo & Company, with a raised target of $41.00. Exelixis was rated Buy by HC Wainwright, with a revised target of $53.00. Expand Energy also received a Buy rating from Mizuho Securities, with a target of $142.00. Expand Energy received a Buy rating from Citi, targeting $140.00. Expeditors International of Washington was rated Hold by Truist Financial, with a revised target of $110.00. Expro Group Holdings received a Buy rating from Wells Fargo, with a target price of $12.00. Fabrinet was rated Buy by Fox Advisors, with a target of $335.00. Federal Signal was rated Outperform by Raymond James Financial, with a raised target of $120.00. First Busey was initiated as Market Perform by Hovde Group, with a target of $25.00. First Solar received a Buy rating from Wells Fargo, with a price target of $177.00. Frequency Electronics received a Buy rating from Freedom Capital Markets, targeting $27.00. Fulcrum Therapeutics was rated Sell by BofA Securities, with a price target of $6.00. Gain Therapeutics received a Buy rating from BTIG, with a price target of $10.00. Gain Therapeutics was rated Buy by Roth MKM, with a target price of $7.00. GeneDx was rated Buy by Guggenheim, with an increased target of $115.00. Genius Sports was rated Market Outperform by JMP Securities, with a raised price target of $13.00. Genpact received a Buy rating from Needham & Company LLC, targeting $50.00. Geo Group was also rated Buy by Texas Capital Securities, with a target of $30.00. Green Brick Partners was initiated with a Neutral rating by B. Riley, with a target of $62.00. Grindr received a Market Outperform rating from JMP Securities, with a raised target of $27.00. Guaranty Bancshares was rated Overweight by Stephens, targeting $47.00. GXO Logistics was rated Hold by Truist Financial, with a revised target of $48.00. Hewlett Packard Enterprise received a Buy rating from Bank of America, with a raised target of $23.00. Hippo Holdings was rated Buy by B.Riley Financial, with a price target of $35.00. Home Depot received a Buy rating from Citi, aiming for $433.00. Home Depot received a Buy rating from Wells Fargo, with a price target of $420.00. Home Depot was rated Outperform by Telsey Advisory Group, targeting $455.00. Howmet Aerospace was rated Outperform by Royal Bank Of Canada. Hyatt Hotels also received a Buy rating from BofA Securities, targeting $150.00. Hyatt Hotels received a Hold rating from Morgan Stanley, targeting $132.00. Hyatt Hotels was rated Buy by Bernstein, targeting $167.00. Iamgold was initiated with a Market Perform rating by Raymond James Financial, targeting $8.00. Indivior was rated Buy by Craig Hallum, with a raised target of $22.00. Inmune Bio was rated Hold by BTIG, with a price target of $21.00. Inuvo received a Buy rating from HC Wainwright, with a target raised to $15.00. Ionis Pharmaceuticals was rated Buy by Barclays, targeting $57.00. It also received a target raise from Wedbush, maintaining the Outperform rating and increasing the price from $16.00 to $18.00. J.B. Hunt Transport Services was rated Hold by Truist Financial, with a new price target of $140.00. Joby Aviation was rated Buy by Canaccord Genuity, with a target of $12.00. KB Home received a Sell rating from CFRA, with a price target of $49.00. Kellanova received a Hold rating from TD Cowen, with a price target of $83.50. Kinross Gold was initiated with a Market Perform rating by Raymond James Financial, targeting $15.00. KKR & Co. Inc. was initiated with an Overweight rating by Piper Sandler, targeting $150.00. Kratos Defense & Security Solutions was upgraded to Buy by The Goldman Sachs Group, targeting $52.00. Krystal Biotech was rated Buy by Clear Street, with a target of $190.00. Largo received a Buy rating from HC Wainwright, targeting $3.70. Lear was rated Buy by Citigroup, with a raised target of $136.00. Leonardo DRS was initiated as Buy by The Goldman Sachs Group, with a target of $49.00. Linde was upgraded to Buy by Citigroup, with a raised target of $535.00. M&T Bank was assigned a Buy rating by RBC Capital, with a target of $200.00. Marathon Petroleum was rated Strong-Buy by Raymond James Financial, with a raised target of $188.00. MasTec was rated Buy by Roth MKM, with a target of $210.00. McDonald's was rated Overweight by KeyCorp, with a revised price target of $325.00. McEwen Mining received a Buy rating from Roth MKM, with a target of $15.00. Medical Properties Trust was rated Sector Perform by Royal Bank Of Canada, with a lowered target of $4.50. Medtronic was upgraded to Peer Perform by Wolfe Research. Microsoft was reiterated with a Positive rating by UBS Group. Mister Car Wash was initiated with a Neutral rating by BTIG Research. Moderna received a Hold rating from Morgan Stanley, targeting $31.00. Neogen was rated Buy by Guggenheim, with a revised target of $10.00. New Gold was initiated with a Market Perform rating by Raymond James Financial, targeting $4.00. Norwegian Cruise Line was rated Neutral by UBS Group, with a reduced price target of $23.00. NOV also received a Hold rating from Citi, targeting $13.00. NOV was rated Sell by Wells Fargo, with a target of $10.00. NU received an Overweight rating from JPMorgan Chase & Co., with a raised target of $16.00. Nuvalent was rated Buy by Goldman Sachs, targeting $105.00. Old Dominion Freight Line was rated Buy by Truist Financial, with an updated target of $180.00. Omeros received a Buy rating from D. Boral Capital, targeting $36.00. Omnicell was rated Buy by Wells Fargo, with a target of $37.00. Oracle also received a Buy rating from TD Cowen, targeting $250.00. Oracle received a Buy rating from Deutsche Bank, with a target of $240.00. Oracle was upgraded to Buy by Stifel Nicolaus, with a target raised to $250.00. OS Therapies was rated Buy by D. Boral Capital, with a target of $20.00. Palomar was rated Outperform by Keefe, Bruyette & Woods, with a revised target of $204.00. Par Pacific received an Outperform rating from Raymond James Financial, with a raised price target of $30.00. Parker Hannifin received a Buy rating from BofA Securities, with a target of $715.00. Pegasystems was rated Buy by Loop Capital, with an increased price target of $60.00. Planet Labs PBC was initiated with a Neutral rating by The Goldman Sachs Group, targeting $4.60. PNC Financial received a Buy rating from RBC Capital, aiming for $195.00. Porch Group received a Buy rating from B.Riley Financial, targeting $15.00. ProKidney was downgraded to Underperform by Bank of America, with a lowered target of $1.00. Protagonist Therapeutics received a Buy rating from Citi, with a price target of $72.00. Qorvo was also rated Hold by Mizuho Securities, targeting $84.00. Regeneron Pharmaceuticals was downgraded to Hold by Argus. Robinhood Markets received a Buy rating from KeyBanc, targeting $110.00. Robinhood Markets was rated Buy by Barclays, targeting $57.00. Roblox received an Overweight rating from JPMorgan Chase & Co., with a raised target of $120.00. Rocket Lab was initiated with a Neutral rating by The Goldman Sachs Group, targeting $27.00. Rocket Pharmaceuticals received a Hold rating from Morgan Stanley, with a target of $7.00. SailPoint was initiated with an Overweight rating by Cantor Fitzgerald, targeting $29.00. Schlumberger received an Overweight rating from JPMorgan Chase & Co., with a lowered target of $44.00. Schlumberger was rated Buy by Wells Fargo, targeting $43.00. SEI Investments was rated Outperform by Oppenheimer, with a raised target of $96.00. SharkNinja, Inc. was rated Buy by Jefferies, with a target of $175.00. Skyworks Solutions received a Hold rating from Mizuho Securities, with a target of $75.00. Smurfit Westrock received an Overweight rating from Barclays, with a slightly lowered target of $63.00. Southern Copper received a Hold rating from UBS, with a price target of $105.00. Starbucks was initiated with an Outperform rating by CICC Research, targeting $100.00. Stevanato Group was reiterated as Outperform by William Blair. Strategy was rated Buy by TD Cowen, targeting $590.00. Summit Therapeutics received a Buy rating from UBS, with a target of $30.00. Synopsys received a Hold rating from Wells Fargo, with a price target of $520.00. TD SYNNEX was rated Buy by Loop Capital, with an increased target of $160.00. Tempus AI was rated Buy by Guggenheim, with a raised target of $75.00. Tesla received a Buy rating from Deutsche Bank, with a price target of $345.00. Tesla was rated Buy by Morgan Stanley, with a price target of $410.00. Tesla was reiterated as Buy by Canaccord Genuity Group, with a target of $303.00. Transdigm Group was rated Buy by BofA Securities, with a price target of $1,615.00. Tronox was downgraded to Underperform by BMO Capital Markets, with a reduced target of $3.00. Tyra Bioscience was rated Buy by Oppenheimer, targeting $30.00. Unifirst received a target price of $197.00 set by Robert W. Baird. Unifirst was rated Underweight by Barclays, with a price target of $152.00. Unifirst was reiterated as Neutral by UBS Group. United Therapeutics was rated Buy by UBS Group, with a lowered target of $385.00. US Bancorp was rated Buy by RBC Capital, with a price target of $50.00. US Gold was assigned a Buy rating by Roth MKM, aiming for $18.00. Valero Energy was rated Strong-Buy by Raymond James Financial, with a raised target of $155.00. Vipshop received an Overweight rating from JPMorgan Chase & Co., with a decreased target of $18.00. Vipshop was given a Hold rating by Citi, with a target of $17.00. Virgin Galactic was initiated with a Neutral rating by The Goldman Sachs Group, targeting $3.00. Vor Biopharma was upgraded to Buy by HC Wainwright, targeting $3.00. Wabash National received a Hold rating from D.A. Davidson, with a target of $9.50. Walt Disney was upgraded to Buy by Jefferies Financial Group, with a target of $144.00. Waystar was initiated with an Outperform rating by Mizuho, targeting $48.00. Whirlpool was upgraded to Buy by Longbow Research, targeting $145.00. Wingstop was rated Buy by BTIG, with a target of $430.00. Winnebago Industries was rated Buy by Benchmark, with a reduced price target of $42.00. XPO was rated Buy by Truist Financial, with a raised target of $135.00. Zai Lab received an Outperform rating from Leerink Partners, with a revised target of $75.00. Zai Lab was assigned a Buy rating by Citi, with a target of $66.00. Zai Lab was rated Buy by Leerink Partners, with a price target of $75.00. Zynex was reiterated as Buy by HC Wainwright, targeting $8.00.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
7 minutes ago
- Globe and Mail
Stock Market News for Jul 3, 2025
U.S. stock markets closed mixed on Wednesday for second consecutive day. Market participants appreciated the U.S.-Vietnam trade deal and expectations of a U.S.-India trade deal. On the other hand, a tepid private jobs data and uncertainty about President Trump's 'Big Beautiful Bill' unnerved investors. The S&P 500 and the Nasdaq Composite ended at record-high level while the Dow finished in negative territory. How Did The Benchmarks Perform? The Dow Jones Industrial Average (DJI) fell 10.25 points to close at 44,484.42. Notably, 17 components of the 30-stock index ended in negative territory and 13 finished in positive zone. The index is currently 1.3% away from its all-time high recorded on Dec 4, 2024. The major gainer of the index was NIKE Inc. NKE. The stock price of the sports retail behemoth was up 4.1% following the U.S.-Vietnam trade deal. NIKE currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. The tech-heavy Nasdaq Composite finished at 20,393.13, rising 0.9% or 190.24 points due to strong performance of technology bigwigs. This was a new record-high closing for the index. The S&P 500 was up 0.5% to finish at 6,227.42, marking a new closing-high. In intraday trading, Wall Street's most observed benchmark posted a new all-time high of 6,227.60. Seven out of 11 broad sectors of the broad-market index ended in positive territory while four in negative zone. The Technology Select Sector SPDR (XLK), the Energy Select Sector SPDR (XLE) and the Materials Select Sector SPDR (XLB) advanced 1.1%, 1.7% and 1.5%, respectively. On the other side, the Health Care Select Sector SPDR (XLV) fell 1%. The fear-gauge CBOE Volatility Index (VIX) was down 1.1% to 16.64. A total of 16.95 billion shares were traded on Wednesday, lower than the last 20-session average of 17.82 billion. Positive Developments on Trade Deals President Donald Trump said that United States has signed a trade deal with Vietnam through which Vietnamese goods will be subject to 20% U.S. tariffs. Vietnam also agreed that a 40% tariff rate will be levied if goods originated in another country and were transferred to Vietnam for final shipment to the United States. Vietnam was subject to a 46% tariff on President Trump's reciprocal tariff chart. President Trump is hopeful that a trade deal between the United States and India could be signed before the July 9 deadline, which ends the 90-dayb pause of tariff imposed by the U.S. administration. India was subject to a 40% tariff on President Trump's reciprocal tariff chart. Trump's Giant Tax and Spending Bill On July 1, U.S. Senate finally cleared President Trump's megabill after prolonged negotiations and a series of amendments by a narrow margin. The bill managed to pass through the Senate with a majority of 51-50. Several Republican Senators voted against the bill defying the party line. The final tie-breaking vote was casted by the Vice President JD Vance. The bill is now headed for the House of Representatives. Last week President Trump pressured the lawmakers to clear the bill to his table by July 4. It is still not clear whether a divided Republican Representatives will pass the bill by the deadline. The nonpartisan Congressional Budget Office projected that the bill will add more than $3 trillion to the federal deficit over the next decade. The U.S. government is currently facing a massive $36.2 trillion of fiscal deficit. Economic Data Automatic Data Processing Inc. ADP reported that U.S. private sector payrolls contracted unexpectedly by 33,000 in June in contrast to the consensus estimate of a gain of 100,000. Jobs addition in May was also revised downward to 29,000 from 37,000 reported earlier. Professional and business services was the hardest hit sector in June. 5 Stocks Set to Double Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%. Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. Today, See These 5 Potential Home Runs >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report NIKE, Inc. (NKE): Free Stock Analysis Report Automatic Data Processing, Inc. (ADP): Free Stock Analysis Report
Globe and Mail
8 minutes ago
- Globe and Mail
Tim Hortons® Camp Day® is back on July 16 with 100% of proceeds from hot and iced coffee sales donated to Tim Hortons Foundation Camps!
Since 1991, Tim Hortons, Tims restaurant owners and guests have collectively raised over $262 million through Camp Day events to support the work of Tim Hortons Foundation Camps, which helps underserved youth reach their full potential. An amazing $12.8 million was raised on Camp Day last year! Starting today, Tims guests can support Tim Hortons Foundation Camps by purchasing a $2 Donation Badge or Camp Day bracelets for $3 , with net proceeds supporting Tims Camps . A Camp Day donut is also available at participating restaurants for $2, with 100 per cent of the proceeds supporting Tims Camps. TORONTO , July 3, 2025 /CNW/ - Camp Day is returning on July 16 at Tim Hortons restaurants across Canada and the United States with 100 per cent of proceeds from every hot coffee and iced coffee sold donated to Tim Hortons Foundation Camps! "For over 30 years, coffee sold on Camp Day has helped support the mission of Tim Hortons Foundation Camps, which is to help youth from underserved communities achieve their full potential," says Axel Schwan , President of Tim Hortons. "Thanks to the incredible generosity of Tims restaurant owners and guests, the Foundation has supported over 325,000 youth in its history. I encourage everyone to join us on July 16 and purchase a hot or iced coffee to help make an impact in the lives of young people who deserve every opportunity to succeed." Camp Day was kickstarted in 1987 by 58 restaurant owners in Atlantic Canada who donated 24 hours of sales to the Tim Horton Children's Camp in Tatamagouche, N.S. The initiative expanded to all Tim Hortons restaurants across Canada in 1991. Tim Hortons, Tims restaurant owners and guests collectively raised over $12.8 million on Camp Day last year and over $262 million has been raised since 1991. "As President of the Tim Hortons Foundation Camps board, and a proud Tims restaurant owner, I'm constantly inspired by the heart of our Tim Hortons community. Camp Day is our biggest fundraiser of the year — and every year, it reminds me what we can achieve when we come together," says Caroline Barham . "With every coffee poured, we're helping youth from underserved communities discover their potential and build brighter futures. That's the true power of Camp Day — and it's something I'm so proud to be part of." Ways to support Tims Camps on Camp Day: 100 per cent of the proceeds from all hot and iced coffee sales are donated to Tim Hortons Foundation Camps. It's a great day to upsize your order and treat your family and friends to a coffee! Order a Tim Hortons Take 12 to share with co-workers, friends and family. A Tim Hortons Take 12 includes 12 small coffees along with cups, dairy and sweeteners. Guests can also fill out a pre-order form in advance for Tim Hortons Take 12s so their whole work team or family can support Camp Day together! Starting today, participating restaurants will offer guests a Camp Day donut for $2, with 100 per cent of the proceeds supporting Tims Camps. Purchase a $2 Donation Badge or Camp Day bracelets for $3 , with net proceeds supporting Tims Camps . Round Up on the Tim Hortons mobile app to support Tims Camps. To round up your order to the nearest 10 cents, open your Tims app, tap on 'Community' or 'Give', and turn on the Round Up toggle. You can also ask a Tim Hortons team member to round up your order to the nearest dollar. Make a one-time or monthly donation online any time at ABOUT TIM HORTONS In 1964, the first Tim Hortons® restaurant in Hamilton, Ontario opened its doors and Canadians have been ordering Tim Hortons iconic Original Blend coffee, Double-Double™ coffees, Donuts and Timbits® in the years since. For more than 60 years, Tim Hortons has captured the hearts and taste buds of Canadians and has become synonymous with serving Canada's favourite coffee. Tim Hortons is Canada's largest restaurant chain operating in the quick service industry with nearly 4,000 restaurants across the country. More than a coffee and bake shop, Tim Hortons is part of the Canadian fabric and guests can enjoy hot and cold specialty beverages – including lattes, cappuccinos and espressos, teas and our famous Iced Capps® – alongside delicious breakfast, sandwiches, wraps, soups and more. Tim Hortons has more than 6,000 restaurants in Canada, the United States and around the world. For more information on Tim Hortons visit SOURCE Tim Hortons
Globe and Mail
8 minutes ago
- Globe and Mail
Best AI Stocks to Buy? Palantir Stock vs. BigBear.ai Stock vs. C3.ai Stock
AI stocks are undoubtedly the hottest stocks in the market in 2025. *Stock prices used were the afternoon prices of June 30, 2025. The video was published on July 2, 2025. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Should you invest $1,000 in Palantir Technologies right now? Before you buy stock in Palantir Technologies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Palantir Technologies wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $697,627!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $939,655!* Now, it's worth noting Stock Advisor 's total average return is1,045% — a market-crushing outperformance compared to178%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 30, 2025 Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Palantir Technologies. The Motley Fool recommends The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
